These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36750933)

  • 41. YAP promotes the proliferation of neuroblastoma cells through decreasing the nuclear location of p27
    Shen X; Xu X; Xie C; Liu H; Yang D; Zhang J; Wu Q; Feng W; Wang L; Du L; Xuan L; Meng C; Zhang H; Wang W; Wang Y; Xie T; Huang Z
    Cell Prolif; 2020 Feb; 53(2):e12734. PubMed ID: 31863533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RNF13 protein regulates endoplasmic reticulum stress induced apoptosis in dopaminergic SH-SY5Y cells by enhancing IRE1α stability.
    Arshad A; Gu X; Arshad M
    J Recept Signal Transduct Res; 2014 Apr; 34(2):119-24. PubMed ID: 24303962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-9 regulates non-small cell lung cancer cell invasion and migration by targeting eukaryotic translation initiation factor 5A2.
    Xu G; Shao G; Pan Q; Sun L; Zheng D; Li M; Li N; Shi H; Ni Y
    Am J Transl Res; 2017; 9(2):478-488. PubMed ID: 28337276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcription Factor FOXO3a Overexpression Inhibits the Progression of Neuroblastoma by Regulating the miR-21/SPRY2/ERK Axis.
    Chen J; Xu Y; Wu P; Chen X; Weng W; Li D
    World Neurosurg; 2022 Aug; 164():e99-e112. PubMed ID: 35405317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Knockdown of EIF5A2 inhibits the malignant potential of non-small cell lung cancer cells.
    Chen C; Zhang B; Wu S; Song Y; Li J
    Oncol Lett; 2018 Apr; 15(4):4541-4549. PubMed ID: 29541224
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long Non-Coding RNA CRNDE Functions as a Tumor Promoter by Modulating the ERK/MAPK Signaling Pathway in Neuroblastoma Cells.
    Zhang T; Fu MC; Tan WQ; Xia HL; Dai S; Xiong QW; Zhou Y; Li ZH; Wu Y; Cao X; Yan XM
    Ann Clin Lab Sci; 2022 Nov; 52(6):956-966. PubMed ID: 36564069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. eIF5A2 regulates the resistance of gastric cancer cells to cisplatin via induction of EMT.
    Sun J; Xu Z; Lv H; Wang Y; Wang L; Ni Y; Wang X; Hu C; Chen S; Teng F; Chen W; Cheng X
    Am J Transl Res; 2018; 10(12):4269-4279. PubMed ID: 30662669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tris (1,3-dichloro-2-propyl) phosphate-induced apoptotic signaling pathways in SH-SY5Y neuroblastoma cells.
    Li R; Zhou P; Guo Y; Lee JS; Zhou B
    Neurotoxicology; 2017 Jan; 58():1-10. PubMed ID: 27816613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytotoxic diarylheptanoid induces cell cycle arrest and apoptosis via increasing ATF3 and stabilizing p53 in SH-SY5Y cells.
    Tian Z; An N; Zhou B; Xiao P; Kohane IS; Wu E
    Cancer Chemother Pharmacol; 2009 May; 63(6):1131-9. PubMed ID: 18836721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LncRNA FTX Contributes to the Progression of Colorectal Cancer Through Regulating miR-192-5p/EIF5A2 Axis.
    Zhao K; Ye Z; Li Y; Li C; Yang X; Chen Q; Xing C
    Onco Targets Ther; 2020; 13():2677-2688. PubMed ID: 32280242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long Noncoding RNA TP73-AS1 Modulates Medulloblastoma Progression In Vitro And In Vivo By Sponging miR-494-3p And Targeting EIF5A2.
    Li B; Shen M; Yao H; Chen X; Xiao Z
    Onco Targets Ther; 2019; 12():9873-9885. PubMed ID: 31819485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical significance of eukaryotic translation initiation factor 5A2 in papillary thyroid cancer.
    Zhang H; Zhang K; Ning L; Chen D; Hao F; Li P
    Bioengineered; 2020 Dec; 11(1):1325-1333. PubMed ID: 33200656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcription of the NKG2D ligand MICA is suppressed by the IRE1/XBP1 pathway of the unfolded protein response through the regulation of E2F1.
    Obiedat A; Seidel E; Mahameed M; Berhani O; Tsukerman P; Voutetakis K; Chatziioannou A; McMahon M; Avril T; Chevet E; Mandelboim O; Tirosh B
    FASEB J; 2019 Mar; 33(3):3481-3495. PubMed ID: 30452881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.
    Huang PY; Zeng TT; Ban X; Li MQ; Zhang BZ; Zhu YH; Hua WF; Mai HQ; Zhang L; Guan XY; Li Y
    BMC Cancer; 2016 Aug; 16(1):669. PubMed ID: 27549330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Downregulation of EIF5A2 by miR-221-3p inhibits cell proliferation, promotes cell cycle arrest and apoptosis in medulloblastoma cells.
    Yang Y; Cui H; Wang X
    Biosci Biotechnol Biochem; 2019 Mar; 83(3):400-408. PubMed ID: 30551723
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Systematic Analysis Revealed the Potential Gene Regulatory Processes of ATRA-Triggered Neuroblastoma Differentiation and Identified a Novel RA Response Sequence in the
    Guo L; Lin W; Zhang Y; Wang J
    Biomed Res Int; 2020; 2020():6734048. PubMed ID: 32149119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long non-coding RNA GAS6-AS1 acts as a ceRNA for microRNA-585, thereby increasing
    Ai J; Sun J; Zhou G; Zhu T; Jing L
    Cell Cycle; 2020 Apr; 19(7):742-757. PubMed ID: 32089066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcriptome Evidence Reveals Mitochondrial Unfolded Protein Response Participate in SH-SY5Y Cells Exposed to Manganese.
    Zhang S; Chen L; Chen T; Zhang Y; Ma J; Ji H; Guo C; Xiao Z; Li J; Niu P
    J Integr Neurosci; 2022 Jul; 21(5):127. PubMed ID: 36137967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of EIF5A2 is associated with poor survival and aggressive tumor biology in gallbladder cancer.
    Zheng X; Gao L; Wang BT; Shen P; Yuan XF; Zhang LQ; Yang L; Zhang DP; Zhang Q; Wang XM
    Histol Histopathol; 2020 Jun; 35(6):579-587. PubMed ID: 31745968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-33a-5p overexpression sensitizes triple-negative breast cancer to doxorubicin by inhibiting eIF5A2 and epithelial-mesenchymal transition.
    Guan X; Gu S; Yuan M; Zheng X; Wu J
    Oncol Lett; 2019 Dec; 18(6):5986-5994. PubMed ID: 31788073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.